Evidence map›Paper›PMID 33344478›Full record

ReviewFrontiers in medicine2020

Role of Growth Differentiation Factor 15 in Lung Disease and Senescence: Potential Role Across the Lifespan.

Faeq Al-Mudares, Samuel Reddick, Jenny Ren, Akshaya Venkatesh, Candi Zhao, Krithika Lingappan

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study.American journal of respiratory and critical care medicine · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Loss of growth differentiation factor 15 exacerbates lung injury in neonatal mice.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Faeq Al-MudaresDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, United States.
Samuel ReddickRice University, Houston, TX, United States.
Jenny RenBaylor College of Medicine, Houston, TX, United States.
Akshaya VenkateshRice University, Houston, TX, United States.
Candi ZhaoRice University, Houston, TX, United States.
Krithika LingappanDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, United States.
Baylor College of Medicine · USRice University · US

Funding

Mechanisms of sex differences in neonatal pulmonary oxygen toxicityR01HL144775 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI LINGAPPAN, KRITHIKA · 2019 to 2023
$2.7M
Leveraging multiomics and advanced mouse models to delineate mechanisms underlying sex‐specific differences in recovery and repair after neonatal hyperoxia exposure in the developing lungR01HL146395 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI LINGAPPAN, KRITHIKA · 2020 to 2023
$1.6M
Sex as biological variable in Bronchopulmonary Dysplasia: Role of the Notch pathwayR21HD100862 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI LINGAPPAN, KRITHIKA · 2020 to 2021
$441k
NHLBI NIH HHS R01 HL144775NHLBI NIH HHS R01 HL146395NICHD NIH HHS R21 HD100862
6 · The paper itself

Abstract

Growth Differentiation Factor 15 (GDF15) is a divergent member of transforming growth factor-beta (TGF-β) superfamily and is ubiquitously expressed, under normal physiological conditions. GDF15 expression increases during many pathological states and serves a marker of cellular stress. GDF15 has multiple and even paradoxical roles within a pathological condition, as its effects can be dose- and time-dependent and vary based on the targeted tissues and downstream pathways. GDF15 has emerged as one of the most recognized proteins as part of the senescence associated secretory phenotype. Cellular senescence plays a major role in many lung diseases across the life-span from bronchopulmonary dysplasia in the premature neonate to COPD and idiopathic pulmonary fibrosis in aged adults. GDF15 levels have been reported to be as a useful biomarker in chronic obstructive pulmonary disease, lung fibrosis and pulmonary arterial hypertension and predict disease severity, decline in lung function and mortality. Glial-cell-line-derived neurotrophic factor family receptor alpha-like (GFRAL) in the brain stem has been identified as the only validated GDF15 receptor and mediates GDF15-mediated anorexia and wasting. The mechanisms and pathways by which GDF15 exerts its pulmonary effects are being elucidated. GDF15 may also have an impact on the lung based on the changes in circulating levels or through the central action of GDF15 activating peripheral metabolic changes. This review focuses on the role of GDF15 in different lung diseases across the lifespan and its role in cellular senescence.

Indexed as

bronchopulmonary dysplasiachronic obstructive pulmonary diseasegrowth differentiation factor 15lung fibrosispulmonary hypertensionsenescence

Identifiers

PMID33344478
PMCPMC7744305
OpenAlexW3109388465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.